Pfenex receives NIAID contract for anthrax vaccine

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded Pfenex Inc. (San Diego, Calif.) a contract worth up to $22.9 million for up to 5 years to develop a dry formulation of its r...